TEVA PHARMACEUTICAL INDUSTRIES LTDTEVAバランスシート

時価総額
$367.1億
PER
ジェネリック・バイオシミラー・革新的医薬品の製造販売の最大手。AJOVYやAUSTEDOなどの主力製品を展開。約500品目、1,400剤型のポートフォリオ。2024年にPivot to Growth戦略実行。米国・欧州・国際市場35カ国超。
2010/122011/122012/122013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/12
現金同等物1,2481,0962,8791,0382,2266,9469889631,7821,9752,1772,1982,8343,2273,300
有価証券36--------------
現金 + 有価証券1,2841,0962,8791,0382,2266,9469889631,7821,9752,1772,1982,8343,2273,300
売掛金5,4766,2135,5725,3385,4085,3507,5237,1285,8225,6764,5814,5293,6963,4083,059
商品及び製品3,8665,0125,5025,0534,3713,9664,9544,9244,7314,4224,4033,8183,8334,0213,007
流動資産合計12,04214,45316,35513,72014,39618,39816,96115,38213,79413,46413,00512,57312,05112,48512,552
有形固定資産4,3575,9476,3156,6356,5356,5448,0737,6736,8686,4366,2965,9825,7395,7504,581
固定資産合計26,11035,68934,25433,78832,02435,86075,92955,23346,88944,00637,63535,09331,95530,99426,774
総資産38,15250,14250,60947,50846,42054,25892,89070,61560,68357,47050,64047,66644,00643,47939,326
一年内返済予定の長期借入金---------1,8312,6741,4032,0861,6491,758
流動負債合計9,69413,84712,88811,96512,28913,00518,51917,92114,32213,67413,16411,02711,46912,24712,796
固定負債合計6,45613,95214,85412,90710,77611,32639,37833,94930,56728,73326,41425,39523,84623,10620,809
総負債16,15027,79927,74224,87223,06524,33157,89751,87044,88942,40739,57936,42235,31535,35333,606
資本金及び資本剰余金13,29513,42413,52413,67814,17117,80923,46323,533,000,00027,26627,36827,50027,61827,74527,86427,822
利益剰余金9,32511,28412,34612,53514,43614,85113,607-3,803-5,958-6,956-10,946-10,529-12,882-13,534-15,173
株主資本22,00222,34322,86722,63623,35529,92734,99318,74515,79415,06311,06111,2448,6918,1265,380
有利子負債合計---------1,8312,6741,4032,0861,6491,758
純有利子負債----------144497-795-748-1,578-1,542
DEレシオ(%)---------12.224.212.52420.332.7